Viewing Study NCT00334477



Ignite Creation Date: 2024-05-05 @ 4:54 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00334477
Status: UNKNOWN
Last Update Posted: 2006-06-07
First Post: 2006-06-06

Brief Title: Efficacy and Safety of Tadalafil in Hemodialysis Patients
Sponsor: University of Pernambuco
Organization: University of Pernambuco

Study Overview

Official Title: Efficacy and Safety of Tadalafil 20mg for the Treatment of Erectile Dysfunction in Chronic Renal Patients in Hemodialysis
Status: UNKNOWN
Status Verified Date: 2006-04
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to check the safety and efficacy of a pde5 inhibitor tadalafil is a special group of patients Renal chronic patients in hemodialysis treatment
Detailed Description: In our country the number of patients in hemodialysis for the treatment of renal chronic dysfunction is very huge As we know this group has a greater prevalence of sexual dysfunction than the general population and among these dysfunctions erectile disfunctionED occupies maybe the most important position

With the advent of the increase aging of the nations population and the small number of organ donations the number of men suffering from ED in hemodialysis surely will be very significant causing a very important problem for our health system

Up to now theres little indexed publications supporting the use of tadalafil in this special group of men Another PDE 5 inhibitor sildenafil was used in this patients with success and safety but obviously we need other options with the same efficacy

We intend this study to give us more background to treat ED in this already unfortunate ones

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None